Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer

NCT07057102 · clinicaltrials.gov ↗
RECRUITING
Status
40
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences